Sex-differences in catecholamine transporter expression in the rodent prefrontal cortex following repetitive mild traumatic brain injury and methylphenidate treatment
International Journal of Neuropsychopharmacology · 2025
DOI: 10.1093/ijnp/pyaf070 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Neuropsychopharmacology, 2025. Verfasst von Eleni Papadopoulos und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Rowan-Virtua School of Osteopathic Medicine, Stratford, NJ, United States. Hauptthemen laut MEDLINE: Methylphenidate, Prefrontal Cortex, Vesicular Monoamine Transport Proteins, Sex Characteristics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: New Jersey Commission on Brain Injury Research, Congressionally Directed Medical Research Programs, United States Department of Defense Traumatic Brain Injury and Physiological Health Research Program.
Abstract (Originalsprache)
Irregular transmitter activity is theorized to underly impaired prefrontal cortex (PFC)-mediated executive functions following repetitive mild traumatic brain injury (rmTBI). The psychostimulant, methylphenidate (MPH), enhances catecholamine neurotransmission by blocking reuptake transporters and is used off-label to treat post-TBI executive dysfunction. Both rmTBI and MPH are known to independently alter catecholamine transporter levels. The present report evaluated the interactive effects of rmTBI and a sub-chronic therapeutic dose of MPH on expression levels of vesicular monoamine transporter-2 (VMAT2) and norepinephrine reuptake transporter (NET) within the medial, anterior cingulate, and orbitofrontal subregions of the PFC in both male and female rats. MPH failed to rescue, and in some cases exacerbated, rmTBI-induced reductions in VMAT2 and NET expression in males, whereas transporter expression was largely unaltered in females. These results suggest MPH treatment produces further protein-level perturbations of catecholaminergic activity that are proposed to underlie executive dysfunction in males, but negligible effects in females, following rmTBI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience, Rowan-Virtua School of Osteopathic Medicine, Stratford, NJ, United States.
- Rowan-Virtua School of Translational Biomedical Engineering and Sciences, Stratford, NJ, United States.
ORCID-Profile: Eleni Papadopoulos
Förderung
- New Jersey Commission on Brain Injury Research
- Congressionally Directed Medical Research Programs
- United States Department of Defense Traumatic Brain Injury and Physiological Health Research Program
- Rowan University Osteopathic Heritage Foundation Endowment for Primary Care Research Award
Zitieren
APA
Papadopoulos, E., Abrimian, A., Knapp, C. P., Loweth, J. A., Waterhouse, B. D., & Navarra, R. L. (2025). Sex-differences in catecholamine transporter expression in the rodent prefrontal cortex following repetitive mild traumatic brain injury and methylphenidate treatment. International Journal of Neuropsychopharmacology. https://doi.org/10.1093/ijnp/pyaf070
Vancouver
Papadopoulos E, Abrimian A, Knapp CP, Loweth JA, Waterhouse BD, Navarra RL. Sex-differences in catecholamine transporter expression in the rodent prefrontal cortex following repetitive mild traumatic brain injury and methylphenidate treatment. International Journal of Neuropsychopharmacology. 2025. doi:10.1093/ijnp/pyaf070
BibTeX
@article{Papadopoulos2025,
author = {Papadopoulos, Eleni and Abrimian, Anna and Knapp, Christopher P and Loweth, Jessica A and Waterhouse, Barry D and Navarra, Rachel L},
title = {Sex-differences in catecholamine transporter expression in the rodent prefrontal cortex following repetitive mild traumatic brain injury and methylphenidate treatment},
journal = {International Journal of Neuropsychopharmacology},
year = {2025},
doi = {10.1093/ijnp/pyaf070}
}
EUVIMED